Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,636 | 40,591 | 126,493 | 26,091 | 0 |
| Marketable Securities | 154,788 | 183,996 | 114,369 | 64,750 | 0 |
| TOTAL | $209,959 | $228,222 | $246,155 | $93,089 | $0 |
| Non-Current Assets | |||||
| PPE Net | 2,408 | 1,078 | 961 | 1,031 | N/A |
| Other Non-Current Assets | 4,003 | 128 | 237 | 3,725 | 0 |
| TOTAL | $6,411 | $1,206 | $1,198 | $4,756 | $N/A |
| Total Assets | $216,370 | $229,428 | $247,353 | $97,845 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,319 | 5,699 | 4,945 | 6,009 | 0 |
| Accrued Expenses | 15,955 | 9,241 | 5,889 | 6,741 | 0 |
| TOTAL | $20,091 | $15,013 | $11,002 | $13,010 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,315 | 0 | 0 | 0 | 0 |
| TOTAL | $3,315 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $23,406 | $15,013 | $11,002 | $13,010 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,386 | 38,269 | 38,266 | N/A | N/A |
| Common Shares | 11 | 11 | 11 | 1 | 0 |
| Retained earnings | -182,069 | -158,207 | -134,927 | -116,952 | 0 |
| Other shareholders' equity | -310 | -390 | 147 | 199,865 | 0 |
| TOTAL | $192,964 | $214,415 | $236,351 | $84,835 | $0 |
| Total Liabilities And Equity | $216,370 | $229,428 | $247,353 | $97,845 | $0 |